1. Home
  2. EVER vs DNA Comparison

EVER vs DNA Comparison

Compare EVER & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EverQuote Inc.

EVER

EverQuote Inc.

N/A

Current Price

$29.10

Market Cap

928.5M

Sector

Technology

ML Signal

N/A

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

N/A

Current Price

$7.61

Market Cap

835.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EVER
DNA
Founded
2008
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
928.5M
835.7M
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
EVER
DNA
Price
$29.10
$7.61
Analyst Decision
Buy
Sell
Analyst Count
8
3
Target Price
★ $32.33
$8.00
AVG Volume (30 Days)
684.7K
★ 2.4M
Earning Date
11-02-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 198.86
46.49
EPS
★ 1.53
N/A
Revenue
$163,349,000.00
★ $170,155,000.00
Revenue This Year
$18.77
N/A
Revenue Next Year
$11.02
$7.59
P/E Ratio
$18.76
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$13.88
$5.37
52 Week High
$31.20
$18.22

Technical Indicators

Market Signals
Indicator
EVER
DNA
Relative Strength Index (RSI) 63.75 36.89
Support Level $22.38 $6.65
Resistance Level $31.20 $7.50
Average True Range (ATR) 1.57 1.18
MACD -0.06 -0.41
Stochastic Oscillator 66.18 0.65

Price Performance

Historical Comparison
EVER
DNA

About EVER EverQuote Inc.

EverQuote Inc operates an online marketplace for insurance shopping, connecting consumers with insurance providers, including carriers and agents. Its marketplace is powered by proprietary data and technology platform that delivers high-intent, pre-validated consumer referrals aligned with insurers underwriting and profitability requirements. The platform provides transparency and campaign management tools, enabling providers to evaluate marketing spend performance and manage return on investment. Consumers can visit insurance provider websites, engage by phone, or submit data to receive quotes. Services are free for consumers, and the company derives revenue principally from consumer inquiries sold as referrals to insurance providers. It derives a majority of revenue from Direct channels.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: